1. TGF-β1-miR-200a-PTEN induces epithelial–mesenchymal transition and fibrosis of pancreatic stellate cells
    Min Xu et al, 2017, Mol Cell Biochem CrossRef
  2. MicroRNA134 Mediated Upregulation of JNK and Downregulation of NFkB Signalings Are Critically Involved in Dieckol Induced Antihepatic Fibrosis
    Sang Yoon Lee et al, 2016, J. Agric. Food Chem. CrossRef
  3. The Potential Role of Elk-3/Egr-1 Signaling Pathway in the Epithelial-Mesenchymal Transition during Liver Fibrosis
    In Hee Kim, 2017, Gut and Liver CrossRef
  4. Anti-fibrotic Effects of Synthetic Oligodeoxynucleotide for TGF-β1 and Smad in an Animal Model of Liver Cirrhosis
    Jung-Yeon Kim et al, 2017, Molecular Therapy - Nucleic Acids CrossRef
  5. Chitin synthesis inhibitors promote liver cancer cell metastasis via interfering with hypoxia-inducible factor 1α
    Xia Ning et al, 2018, Chemosphere CrossRef
  6. p300/CBP as a Key Nutritional Sensor for Hepatic Energy Homeostasis and Liver Fibrosis
    Weilei Yao et al, 2018, BioMed Research International CrossRef
  7. Ginsenoside Rg1 ameliorates liver fibrosis via suppressing epithelial to mesenchymal transition and reactive oxygen species production in vitro and in vivo.
    Xiaoyu Wei et al, 2018, Biofactors CrossRef
  8. Distribution of Connective Tissue in the Male and Female Porcine Liver: Histological Mapping and Recommendations for Sampling
    P. Mik et al, 2018, Journal of Comparative Pathology CrossRef
  9. Long-chain fatty acid activates hepatocytes through CD36 mediated oxidative stress
    Jun Liu et al, 2018, Lipids Health Dis CrossRef
  10. Epithelial mesenchymal transition (EMT): a universal process in lung diseases with implications for cystic fibrosis pathophysiology.
    Nathan Rout-Pitt et al, 2018, Respir Res CrossRef
  11. Antifibrotic Effect of Smad Decoy Oligodeoxynucleotide in a CCl4-Induced Hepatic Fibrosis Animal Model
    Mi-Gyeong Gwon et al, 2018, Molecules CrossRef
  12. Dietary exacerbation of metabolic stress leads to accelerated hepatic carcinogenesis in glycogen storage disease type Ia
    Monika Gjorgjieva et al, 2018, Journal of Hepatology CrossRef
  13. PCAF fine-tunes hepatic metabolic syndrome, inflammatory disease, and cancer
    Tongxin Wang et al, 2018, J Cell Mol Med CrossRef
  14. Anti-fibrotic impact of Carvedilol in a CCl-4 model of liver fibrosis via serum microRNA-200a/SMAD7 enhancement to bridle TGF-β1/EMT track
    Sara A. El-Wakeel et al, 2018, Sci Rep CrossRef
  15. Current therapies and novel approaches for biliary diseases
    Indu G Rajapaksha et al, 2019, WJGP CrossRef
  16. Preclinical insights into cholangiopathies: disease modeling and emerging therapeutic targets
    Keisaku Sato et al, 2019, Expert Opinion on Therapeutic Targets CrossRef
  17. Cadherin-11 contributes to liver fibrosis induced by carbon tetrachloride
    Mesias Pedroza et al, 2019, PLoS ONE CrossRef
  18. Hepatitis B virus X protein enhances the development of liver fibrosis and the expression of genes associated with epithelial-mesenchymal transitions and tumor progenitor cells
    James Ahodantin et al, 2019 CrossRef
  19. The relationship between molecular content of mesenchymal stem cells derived exosomes and their potentials: opening the way for exosomes based therapeutics
    Davod Jafari et al, 2019, Biochimie CrossRef
  20. Human umbilical cord mesenchymal stem cells ameliorate liver fibrosis in vitro and in vivo: From biological characteristics to therapeutic mechanisms
    Fei Yin et al, 2019, WJSC CrossRef
  21. Advanced oxidation protein products induce hepatocyte epithelial-mesenchymal transition via a ROS-dependent, TGF-β/Smad signaling pathway
    Shibo Sun et al, 2017, Cell Biol Int CrossRef
  22. Ginsenoside Rg1 Attenuates Cigarette Smoke-Induced Pulmonary Epithelial-Mesenchymal Transition via Inhibition of the TGF-β1/Smad Pathway
    Sibin Guan et al, 2017, BioMed Research International CrossRef
  23. Liver‐Targeted Angiotensin Converting Enzyme 2 Therapy Inhibits Chronic Biliary Fibrosis in Multiple Drug‐Resistant Gene 2‐Knockout Mice
    Indu G. Rajapaksha et al, 2019, Hepatol Commun CrossRef
  24. The role of DUBs in the post-translational control of cell migration
    Guillem Lambies et al, 2019 CrossRef
  25. Increased Expression of Adherens Junction Components in Mouse Liver following Bile Duct Ligation
    null Van Campenhout et al, 2019, Biomolecules CrossRef
  26. TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis-Updated 2019.
    Bedair Dewidar et al, 2019, Cells CrossRef
  27. TGF-β1 mediated Smad signaling pathway and EMT in hepatic fibrosis induced by Nano NiO in vivo and in vitro.
    Qiong Zhang et al, 2020, Environ Toxicol CrossRef
  28. The Versatile Role of Matrix Metalloproteinase for the Diverse Results of Fibrosis Treatment
    Hong-Meng Chuang et al, 2019, Molecules CrossRef
  29. 3D bioprinting of liver spheroids derived from human induced pluripotent stem cells sustain liver function and viability in vitro
    Ernesto Goulart et al, 2019, Biofabrication CrossRef
  30. Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
    Natascha Roehlen et al, 2020, Cells CrossRef
  31. Alteration of miR-21, miR-433 and miR-590 tissue expression related to the TGF-β signaling pathway in ulcerative colitis patients
    Mehri Naghdalipour et al, 2020, Archives of Physiology and Biochemistry CrossRef
  32. Study on the relationship between hepatic fibrosis and epithelial-mesenchymal transition in intrahepatic cells
    Yang Chen et al, 2020, Biomedicine & Pharmacotherapy CrossRef
  33. Emodin alleviates CCl4‑induced liver fibrosis by suppressing epithelial‑mesenchymal transition and transforming growth factor‑β1 in rats
    Feng Liu et al, 2018, Mol Med Report CrossRef
  34. Human umbilical cord mesenchymal stem cells inhibit proliferation of hepatic stellate cells in vitro
    Li-Ting Zhang et al, 2018, Int J Mol Med CrossRef
  35. Effects of bradykinin on TGF‑β1‑induced epithelial‑mesenchymal transition in ARPE‑19 cells
    Qingquan Wei et al, 2018, Mol Med Report CrossRef
  36. Sequential Matrix Metalloproteinase-1 Expression Triggered by Infiltrating Monocytic Lineage Cells Modulates Pathophysiological Aspects of Human Nonalcoholic Steatohepatitis

    Isao Okazaki et al, 2020, MNM CrossRef
  37. Effect of human umbilical cord mesenchymal stem cells transfected with HGF on TGF-β1/Smad signaling pathway in CCl4-induced liver fibrosis rats
    Fei Yin et al, 2020, Stem Cells and Development CrossRef
  38. Piperlongumine attenuates bile duct ligation-induced liver fibrosis in mice via inhibition of TGF-β1/Smad and EMT pathways
    Shrilekha Chilvery et al, 2020, International Immunopharmacology CrossRef
  39. Induction of Surgical Obstructive Cholestasis in rats: morphological, biochemical and immunohistochemical changes
    Nermeen Elsaied et al, 2020, Mans Vet Med J CrossRef
  40. PM014 attenuates radiation-induced pulmonary fibrosis via regulating NF-kB and TGF-b1/NOX4 pathways
    Sung-Hyo Park et al, 2020, Sci Rep CrossRef
  41. Emerging cellular and molecular determinants of idiopathic pulmonary fibrosis
    Thị Hằng Giang Phan et al, 2020, Cell. Mol. Life Sci. CrossRef
  42. Dual Pharmacological Targeting of HDACs and PDE5 Inhibits Liver Disease Progression in a Mouse Model of Biliary Inflammation and Fibrosis
    Alex Claveria-Cabello et al, 2020, Cancers CrossRef
  43. Current Concepts of Biliary Atresia and Matrix Metalloproteinase-7: A Review of Literature
    Mark Nomden et al, 2020, Front. Med. CrossRef
  44. The Epithelial-to-Mesenchymal Transition as a Possible Therapeutic Target in Fibrotic Disorders
    Jacopo Di Gregorio et al, 2020, Front. Cell Dev. Biol. CrossRef
  45. Immune Inhibitory Properties and Therapeutic Prospects of Transforming Growth Factor-Beta and Interleukin 10 in Autoimmune Hepatitis
    Albert J. Czaja, 2021, Dig Dis Sci CrossRef
  46. MicroRNA-34a Promotes EMT and Liver Fibrosis in Primary Biliary Cholangitis by Regulating TGF-β1/smad Pathway
    Ying Pan et al, 2021, Journal of Immunology Research CrossRef
  47. Exome sequence association study of levels and longitudinal change of cardiovascular risk factor phenotypes in European Americans and African Americans from the Atherosclerosis Risk in Communities Study
    Elena V. Feofanova et al, 2021, Genetic Epidemiology CrossRef
  48. In Vitro and In Vivo Study on the Toxic Effects of Propiconazole Fungicide in the Pathogenesis of Liver Fibrosis
    Hyuk Cheol Kwon et al, 2021, J. Agric. Food Chem. CrossRef
  49. ADAM 17 and Epithelial-to-Mesenchymal Transition: The Evolving Story and Its Link to Fibrosis and Cancer
    Margherita Sisto et al, 2021, JCM CrossRef
  50. Stationed or Relocating: The Seesawing EMT/MET Determinants from Embryonic Development to Cancer Metastasis
    Chien-Hsiu Li et al, 2021, Biomedicines CrossRef
  51. Pcyt2 deficiency causes age-dependant development of nonalcoholic steatohepatitis and insulin resistance that could be attenuated with phosphoethanolamine
    Sophie Grapentine et al, 2022, Sci Rep CrossRef
  52. Progesterone differentially affects the transcriptomic profiles of cow endometrial cell types
    Gonçalo Pereira et al, 2022, BMC Genomics CrossRef
  53. Intravital imaging reveals inflammation as a dominant pathophysiology of age-related hepatovascular changes
    Ravi Vats et al, 2022, American Journal of Physiology-Cell Physiology CrossRef
  54. Senescence-Associated Cell Transition and Interaction (SACTAI): A Proposed Mechanism for Tissue Aging, Repair, and Degeneration
    Yajun Liu et al, 2022, Cells CrossRef
  55. Cholesterol-Mediated Seeding of Protein Corona on DNA Nanostructures for Targeted Delivery of Oligonucleotide Therapeutics to Treat Liver Fibrosis
    Kyoung-Ran Kim et al, 2022, ACS Nano CrossRef
  56. Layered Double Hydroxides-Loaded Sorafenib Inhibit Hepatic Stellate Cells Proliferation and Activation In Vitro and Reduce Fibrosis In Vivo
    Wei Peng et al, 2022, Front. Bioeng. Biotechnol. CrossRef
  57. Mesenchymal Stem Cell-Derived Extracellular Vesicles as Idiopathic Pulmonary Fibrosis Microenvironment Targeted Delivery
    Lu Sang et al, 2022, Cells CrossRef
  58. Mesenchymal stem cells in fibrotic diseases—the two sides of the same coin
    Lei Qin et al, 2022, Acta Pharmacol Sin CrossRef
  59. A Molecular Mechanism Study to Reveal Hirudin’s Downregulation to PI3K/AKT Signaling Pathway through Decreasing PDGFRβ in Renal Fibrosis Treatment
    Ying Li et al, 2022, BioMed Research International CrossRef
  60. Investigation of the effects of marsupialization on histomorphological and immunohistochemical markers of odontogenic keratocysts
    E Baris et al, 2022, Niger J Clin Pract CrossRef
  61. Enhanced Expression of ARK5 in Hepatic Stellate Cell and Hepatocyte Synergistically Promote Liver Fibrosis
    Yang You et al, 2022, IJMS CrossRef
  62. High SNAIL Expression Reflects Of Recurrence After Resection Colorectal Cancer Liver Metastasis
    Ahmet KARAMUSTAFAOĞLU et al, 2022 CrossRef
  63. Current view of liver cancer cell-of-origin and proposed mechanisms precluding its proper determination
    Tomasz Gromowski et al, 2023, Cancer Cell Int CrossRef
  64. Oxy210, a Semi-Synthetic Oxysterol, Inhibits Profibrotic Signaling in Cellular Models of Lung and Kidney Fibrosis
    Feng Wang et al, 2023, Pharmaceuticals CrossRef
  65. An updated review on phytochemistry and molecular targets of Withania somnifera (L.) Dunal (Ashwagandha)
    Arsalan Bashir et al, 2023, Front. Pharmacol. CrossRef
  66. Colorectal cancer-derived small extracellular vesicles induce TGFβ1-mediated epithelial to mesenchymal transition of hepatocytes
    Marzia Pucci et al, 2023, Cancer Cell Int CrossRef
  67. Role of Ferroptosis in Fibrosis Diseases
    Zhiyong Sun et al, 2023, The American Journal of the Medical Sciences CrossRef
  68. The Elk-3 target Abhd10 ameliorates hepatotoxic injury and fibrosis in alcoholic liver disease
    Tian-Zhu Li et al, 2023, Commun Biol CrossRef
  69. null
    Yelda Yüregir et al, 2023 CrossRef
  70. Cellular heterogeneity and plasticity during NAFLD progression
    Hyun-Ju Park et al, 2023, Front. Mol. Biosci. CrossRef
  71. Methylmalonic acid in aging and disease
    Joanne Tejero et al, 2023, Trends in Endocrinology & Metabolism CrossRef
  72. Autophagy modulates physiologic and adaptive response in the liver
    Trinh Van Le et al, 2023, Liver Research CrossRef
  73. The inhibition of YAP Signaling Prevents Chronic Biliary Fibrosis in the Abcb4-/- Model by Modulation of Hepatic Stellate Cell and Bile Duct Epithelium Cell Pathophysiology
    Liangtao Ye et al, 2024, Aging and disease CrossRef
  74. DCDC2 inhibits hepatic stellate cell activation and ameliorates CCl4-induced liver fibrosis by suppressing Wnt/β-catenin signaling
    Qing-Qing Liu et al, 2024, Sci Rep CrossRef
  75. Current research insights into the role of CTLA‐4 in hepatitis B virus (HBV) infection
    Qi Gu et al, 2024, Journal of Viral Hepatitis CrossRef
  76. Progress of mesenchymal stem cells (MSCs) & MSC-Exosomes combined with drugs intervention in liver fibrosis
    Yan Xu et al, 2024, Biomedicine & Pharmacotherapy CrossRef